BRWD3 Polyclonal Antibody

Rabbit Anti-BRWD3 Polyclonal Antibody

Product Specifications

Background

The bromodomain and WD repeat domain containing 3 encoded by BRWD3 contains a bromodomain and several WD repeats. It is thought to have a chromatin-modifying function, and may thus play a role in transcription. Mutations in this gene cause mental retardation X-linked type 93, which is also referred to as mental retardation X-linked with macrocephaly. This gene is also associated with translocations in patients with B-cell chronic lymphocytic leukemia.

CAS Number

9007-83-4

Product Name Alternative

BRWD3; Bromodomain and WD repeat-containing protein 3

Gene ID

254065

Accession Number

Q6RI45

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from the C-terminal region of human BRWD3 at AA rangle: 1720-1800

Clonality

Polyclonal

Tag

Bromodomain and WD repeat-containing protein 3

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

204kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

BRWD3 Polyclonal Antibody detects endogenous levels of BRWD3 protein.

Observed Molecular Weight

204

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:40000; IF 1:50-200